Large-scale testing (Phase 3)Study completedNCT00391131What this trial is testingSubcutaneous Ig NextGen 16% in PID PatientsWho this might be right forPrimary Immunodeficiency (PID) CSL Limited 35
Testing effectiveness (Phase 2)Study completedNCT00267865What this trial is testingChemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaWho this might be right forAIDS-Related-Primary Central Nervous System Lymphoma National Cancer Institute (NCI) 12
Not applicableUnknownNCT01354587What this trial is testingEvaluation of Efficacy and Tolerability of Hizentra®Who this might be right forPrimary Immunodeficiency Disorders University of South Florida 50
Large-scale testing (Phase 3)Study completedNCT02269163What this trial is testingStudy of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%Who this might be right forPrimary Immunodeficiency Prometic Biotherapeutics, Inc. 82
Not applicableLooking for participantsNCT00055172What this trial is testingGenetic Basis of ImmunodeficiencyWho this might be right forSevere Combined Immunodeficiency National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableStudy completedNCT04804072What this trial is testingINTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery UnitWho this might be right forHIV InfectionsDrug UseOpioid Use+1 more HIV Prevention Trials Network 447
Testing effectiveness (Phase 2)Study completedNCT00176865What this trial is testingStem Cell Transplant for Immunologic or Histiocytic DisordersWho this might be right forHemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT01050465What this trial is testingMedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic UseWho this might be right forAcne VulgarisAllergic RhinitisAnxiety+34 more University of Missouri-Columbia 907
Large-scale testing (Phase 3)Study completedNCT00168012What this trial is testingEfficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)Who this might be right forAgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency CSL Behring 42
Not applicableStudy completedNCT03029728What this trial is testingBiomarker for Hereditary AngioEdema DiseaseWho this might be right forC1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more CENTOGENE GmbH Rostock 42
Large-scale testing (Phase 3)Study completedNCT02817451What this trial is testingDTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected InfantsWho this might be right forDiphtheriaTetanusPertussis+3 more Sanofi Pasteur, a Sanofi Company 53
Large-scale testing (Phase 3)Looking for participantsNCT07298447What this trial is testingDonidalorsen Treatment in Children With Hereditary AngioedemaWho this might be right forHereditary Angioedema (HAE) Ionis Pharmaceuticals, Inc. 20
Post-approval studies (Phase 4)UnknownNCT00124358What this trial is testingBuprenorphine and Integrated HIV Care EvaluationWho this might be right forOpioid-Related DisordersHIV InfectionsAIDS The New York Academy of Medicine 1,350
Large-scale testing (Phase 3)Study completedNCT00462709What this trial is testingOpen-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksWho this might be right forHereditary Angioedema Shire 146
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Testing effectiveness (Phase 2)Study completedNCT01826916What this trial is testingEDEMA2: Evaluation of DX-88's Effect in Mitigating AngioedemaWho this might be right forHereditary Angioedema (HAE) Shire 77
Not applicableNot Yet RecruitingNCT06519734What this trial is testingPrimitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene ProductsWho this might be right forPrimary Immune Deficiency Diseases Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT03716700What this trial is testingReal-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)Who this might be right forPrimary Immunodeficiency Diseases (PID) Baxalta now part of Shire 126
Post-approval studies (Phase 4)Study completedNCT04566692What this trial is testingEvaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary ImmunodeficiencyWho this might be right forPrimary Immunodeficiency Grifols Therapeutics LLC 33
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115